According to GlobalData’s medical device pipeline database, 73 Interbody Devices devices are in various stages of development globally. GlobalData’s report Interbody Devices provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.

Smarter leaders trust GlobalData

Of these devices, 26 are in active development, while the remaining 48 are in an inactive stage of development. There are 14 products in the early stages of development, and the remaining 12 are in the late stages of development.

Interbody fusion cage devices use a hollow threaded titanium or carbon fiber cylinder to fuse two vertebrae together to treat degenerative disc disease to provide fixation. During the surgery process, the diseased/ruptured vertebral disc is replaced by interbody cages. Interbody devices are made up of materials such as metals usually titanium, machined bone allograft, PEEK (polyetheretherketone) and others which include ceramics and carbon fiber. Depending upon surgical approach followed, thoraco-lumbar spinal procedures involving interbody devices are divided into four types namely Anterior lumbar interbody fusion (ALIF), Posterior lumbar interbody fusion (PLIF), Transforaminal lumbar interbody fusion (TLIF) and Lateral lumbar interbody fusion (LLIF). As LLIF procedures are entirely performed by minimal invasive techniques, this segment is not tracked in this sub-segment. Only volume of conventional thoraco-lumbar spinal procedures involving interbody devices (ALIF, TLIF and PLIF) are considered in this sub-segment. Bone allograft is tracked under a separate individual model “Bone Graft Substitutes and Allograft”. One unit refers to one interbody device.

Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.

Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Interbody Devices pipeline devices are all expected to be approved within the next ten years.

Currently, private organizations, public entities and institutions are working on the development of Interbody Devices devices. Overall, most of these Interbody Devices pipeline devices are being developed by private entities.

Key players involved in the active development of Interbody Devices include Curiteva, SINTX Technologies, Corelink, ZygoFix, University of South Florida, University of Toledo, Eminent Spine, Fuse Medical, Alphatec and Bio2 Technologies.

For a complete picture of the developmental pipeline for Interbody Devices devices, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.